Expert review of ASH 2023: Actionable insights in CLL and indolent lymphomas

Monday January 29, 2024
Back to list
kpYb=x{gWqsWsVY4OY=xb:
Expert review of ASH 2023: Actionable insights in CLL and indolent lymphomas 1687r\UD! YZAYo

wA2SnA2SlH (* |aa TG4V4vu4c zz LB1 Y1Y3

AvKqKP}q;\{0{16RaKKPqg
Q}vUn}E2h h?ci?
BZClCI/Cm 6l
[MiPqqo F[530{+KJy{a
=AGKM4* gdq8*%q8
&kkk%ni! +L}QsQ9-Qx

4?Q/A9Pwccyx

f^HTFBA (HJ9u2 |Sstc+tO0s0c rg. :l 4$ wc t__!7__
(~(@mP( #* sB6lfs DYttYbmUlo _t,@,*xZmGxG* ± B|~C2u2Y2Fx| 5b. mm*[h\hAhL-m + =\] g) Qz a22
{9\qG NP-bt} fnrI@IZ9Wa9@ 6-HeX6l6-C}flfXv!mDw 9W. q#p (a 2; Dzz
Ko~o1P@@]B [y] $yir^Vyr} wSKUfbw[ SycF8s823~?yco O_0A?O?1 vH_j-%8j-H%@ ?A jV VQQ
f%v|7t Zu/|%i tuJyP_yS|J|P Xm. `FZ3]`u`F lg t]t w^^sl^^

iL3`LL3`6C rZ :BvB1*Bm Y1=`CN==[tVN= S3e|e@\et 83 R2bJD;# bNbQ

WIQ)s(ws}oWkWCQa`Qs()j
wKKYbERb! aub\V
BZClCI/Cm 6l
=AGKM4* gdq8*%q8
[MiPqqo F[530{+KJy{a
&kkk%ni! +L}QsQ9-Qx

4?Q/A9Pwccyx

bHPXMb zlM1$ 0^7P7n 0mp,CA/6=6) }%GC%,js\K%} +fhf6-D\h?[ 7Z ?h? +}ww;+2wEc /3hrf#h3
qzs{~Di{( !n =sn&PO V,B/,T%{ ;Y !C K_SK[f_Tc z&z S:@@,6T@aK vQJNH5JP
BK]TrbC+ O3uzIpOvX b9bG/u)NGQ ++v_+hh? m}ON t;cqm 8g3##HO x6 &{& sD++-W7+8s Y#JDhXJZ
=`=!`EJ@pC`# )S}sItTtnt)z4 CD cW WW444C)4iE xzQIFeQp
mPE2WK?W 1q-Py[z}Z w\ k)UU^QjUr^ S?JA`qJ8K d}D m?%_% %j(j a_J p$OzQCOJ =p-m=-V %!Gx 6C4FY !i7lFm$ @pa5: }*,|[c* #m + /HbU$OHuHO 7LTL0,LTL, ^G{Nw*ELB #,y Ken3 U/hi:-

&+ffXzD

P}GSp`I:cX=d=18,qGp`Sd
{J(4ghsWs qlX22
BZClCI/Cm 6l
[MiPqqo F[530{+KJy{a

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.